FDA says public shouldn't use antibody tests to determine COVID-19 immunity

• The FDA has issued a safety announcement that the public should not use the results of SARS-CoV-2 antibody tests to determine immunity or protection against COVID-19.
• The tests should only be used to determine if someone has been exposed to SARS-CoV-2 in the past and developed an immune response.
• Some SARS-CoV-2 test makers in afternoon trading: Ortho Clinical Diagnostics (NASDAQ:OCDX) +2.9%; QIAGEN (NYSE:QGEN) +1.1%; Danaher (NYSE:DHR) (-0.8%); Abbott (NYSE:ABT) -0.5%; and Siemens (OTCPK:SIEGY) -2.9%.